PEG-INTERFERON相关论文
Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treat
...
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)id
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepa
AIM: To evaluate the impact of therapeutic education on adherence to antiviral treatment and sustained virological respo......
Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition
The main goals of treating cirrhotic patients with antiviral therapy are to attain sustained viral clearance(SVR),halt d......
目的观察并分析聚乙二醇化干扰素（Peg IFNα-2α）联合利巴韦林治疗慢性丙型肝炎的疗效及其影响因素。方法回顾性分析2010年1月至2015......
目的：分析聚乙二醇化干扰素（PegIFN）联合利巴韦林治疗对慢性丙型肝炎的疗效及影响因素。方法使用聚PegIFNα-2a（派罗欣180μg/周）联合利......
Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition
与抗病毒的治疗对待肝脏硬化症的病人的主要目标是达到持续病毒的清理(SVR ) ，停止疾病前进，并且阻止肝接枝的再感染。然而，当医药需......
Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained vi
瞄准：为了在肝炎三角洲病毒(HDV ) 的治疗观察木钉干扰素的功效并且识别因素，那将持续病毒的反应(SVR ) 是预兆的。方法：这未来的研究......
Analysis of peripheral blood dendritic cells as a non-invasivetool in the follow-up of patients with
Hepatitis C virus （HCV） has a high propensity toestablish chronic infections. Failure of HCV-infectedindividuals to activa......
Injection drug users(IDUs)are at risk of hepatitis C virus(HCV)infection,due to needle and syringe sharing.Chronic HCV i......
慢性乙型肝炎（CHB）患者的干扰素（IFN）抗病毒疗效受病毒自身和宿主等因素的影响,而宿主的细胞免疫状态是IFN应答的重要因素之一。本文采......
